The damage done by the war on opioids: The pendulum has swung too far

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 265-268

  Atkinson, Timothy J ^a   Schatman, Michael E ^b   Fudin, Jeffrey ^a,c,d,e  

^a STRATTON VA MEDICAL CENTER   (United States)

^b Foundation for Ethics in Pain Care   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d WESTERN NEW ENGLAND UNIVERSITY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; DRUG APPROVAL; DRUG EFFICACY; DRUG MISUSE; DRUG MONITORING; DRUG OVERDOSE; DRUG SAFETY; DRUG UTILIZATION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; NON CANCER PAIN; OPIATE ADDICTION; PAIN; PATIENT SELECTION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TREND STUDY; UNITED STATES;

EID: 84900450485     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S65581     Document Type: Editorial

References (20)

1. Joint Commission on Accreditation of Healthcare Organizations. Comprehensive Accreditation Manual for Ambulatory Care. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2006.
2. US. Department of Health and Human Services National Institutes of Health. NIH News. Analysis of opioid prescription practices finds areas of concern. Available from: http://www.nih.gov/news/health/apr2011/nida-05.htm. Accessed March 1, 2014.
3. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.
4. Walwyn WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010;108(3):156-165.
5. Federation of State Medical Boards of the United States, Inc. Model policy for the use of controlled substances for the treatment of pain. J Pain Palliat Care Pharmacother. 2005;19(2):73-78.
6. Salinas GD, Robinson CO, Abdolrasulnia M. Primary care physician attitudes and perceptions of the impact of FDA-proposed REMS policy on prescription of extended-release and long-acting opioids. J Pain Res. 2012;5:363-369.
7. United States Food and Drug Administration. FDA/CDER Response to Physicians for Responsible Opioid Prescribing Partial Petition Approval and Denial. Available from: http://www.regulations.gov/#!documentDetail;D=FDA-2012-P-0818-0793. Accessed March 1, 2014.
8. Schatman ME. Interdisciplinary chronic pain management: international perspectives. Pain: Clinical Updates. 2012;20(7):1-5.
9. Passik SD. Tamper-resistant opioid formulations in the treatment of acute pain. Adv Ther. 2014;31(3):264-275.
10. Fudin J, Atkinson T. Opioid prescribing levels off, but is less really more? Pain Med. 2014;15(2):184-187.
11. Institute of Medicine of the National Academies. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press (US); 2011.
12. Martin TW. Making the 'Pharmacy Crawl'. Wall Street Journal. September 26, 2012. Available from: http://online.wsj.com/news/articles/SB10000872396390443720204578004873138298306. Accessed March 10, 2014.
13. Acker C. Opium: US. Overview. In: Korsmeyer P, Kranzler H, editors. Encyclopedia of Drugs, Alcohol, and Addictive Behavior. 3rd ed. New York, NY: Macmillan Reference USA; 2009:183-189.
14. Kandall S. Substance and Shadow: Women and Addiction in the United States. Cambridge, MA: Harvard University Press; 1996.
15. Schatman ME. The role of the health insurance industry in perpetuating suboptimal pain management: ethical implications. Pain Med. 2011;12: 415-426.
16. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444-459.
17. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605.
18. Akbik H, Butler SF, Budman SH, et al. Validation and clinical application of the Screener and Opioid Assessment for patients with pain (SOAPP). J Pain Sym Manage. 2006;32:287-293.
19. Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440-459.
20. Wilson HD, Dansie EJ, Kim MS, Moskovitz BL, Chow W, Turk DC. Clinicians' attitudes and beliefs about opioids survey (CAOS): instrument development and results of a national physician survey. J Pain. 2013;14(6):613-627.